Remdesivir Recruiting Phase 4 Trials for Pneumonia / Coronavirus Disease 2019 (COVID‑19) Treatment

Indications	Status	Purpose	Phase
DBCOND0014196 (Pneumonia) DBCOND0129755 (Coronavirus Disease 2019 (COVID‑19))	Recruiting	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT04779047	Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.	Hydroxychloroquine (DB01611) Ivermectin (DB00602) Lopinavir (DB01601) Remdesivir (DB14761) Ritonavir (DB00503) Tocilizumab (DB06273)